Certain medications can interact with multivitamins, making them less effective.

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

Esperion Therapeutics (NASDAQ:ESPR) executives told investors the company delivered its “strongest performance to date” in ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

Esperion Therapeutics has entered into a definitive agreement to acquire Corstasis Therapeutics, a privately held biopharmaceutical company. The acquisition focuses on the integration of Enbumyst™ ...

Esperion has acquired Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago.

Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to ...

Little is known about the initial dosing of loop diuretics among patients hospitalized for heart failure and its association with outcomes. Despite decades of experience with intravenous loop ...

ProtoPie has launched ProtoPie AI in Open Beta, introducing a disruptive "Human-in-the-Loop" workflow that combines AI ...

How come it feels like it's all bad news in the global economy these days? According to one economist, something he calls the "doom loop." Between trade wars, rising inflation and industries going ...